Biochemical Failure Is Not a Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
J. Clin. Oncol 2022 Jun 23;[EPub Ahead of Print], WC Jackson, M Tang, MJ Schipper, HM Sandler, ZS Zumsteg, JA Efstathiou, WU Shipley, W Seiferheld, HR Lukka, JP Bahary, AL Zietman, TM Pisansky, KL Zeitzer, WA Hall, RT Dess, RD Lovett, AG Balogh, FY Feng, DE SprattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.